Click it and Unblock the Notifications
Sensex
84,929.36
+0.53%
|
Nifty
25,966.40
+0.58%
|
22k Gold
₹ 12,300 /gm
|
Silver
₹ 2,14,000/kg
|
Petrol
₹ 103.54
|
Diesel
₹ 90.03
|
Crude Oil
$60.34
|
USD
₹
89.58
|
Sensex
84,929.36
+0.53%
|
Nifty
25,966.40
+0.58%
|
22k Gold
₹ 12,300 /gm
|
Silver
₹ 2,14,000/kg
|
Petrol
₹ 103.54
|
Diesel
₹ 90.03
|
Crude Oil
$60.34
|
USD
₹
89.58
|
Sensex
84,929.36
+0.53%
|
Nifty
25,966.40
+0.58%
|
22k Gold
₹ 12,300 /gm
|
Silver
₹ 2,14,000/kg
|
Petrol
₹ 103.54
|
Diesel
₹ 90.03
|
Crude Oil
$60.34
|
USD
₹
89.58
Balance Sheet of GlaxoSmithKline Pharmaceuticals Ltd. Company
| (Rs in Cr.) | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 |
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| Share Application Money | 0.00 | -9.01 | -1.68 | 0.00 | 0.00 |
| Preference Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reserves & Surplus | 1,779.82 | 1,623.69 | 1,585.27 | 2,508.21 | 1,327.71 |
| Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Unsecured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Block | 579.25 | 604.38 | 585.48 | 553.28 | 571.90 |
| Depreciation | 295.62 | 283.13 | 255.54 | 222.66 | 185.01 |
| Net Block | 283.63 | 321.25 | 329.94 | 330.63 | 386.89 |
| Capital Work-in-progress | 14.32 | 13.93 | 20.31 | 30.50 | 13.21 |
| Investments | 1,142.74 | 837.72 | 542.78 | 390.09 | 24.49 |
| Current Assets, Loans & Advances | 2,660.24 | 2,374.90 | 2,434.67 | 3,871.38 | 2,672.48 |
| Total Net Current Assets | 508.54 | 611.19 | 859.97 | 1,926.40 | 1,072.54 |
| Miscellaneous expenses not written | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book Value of Unquoted Investments | 24.49 | 24.49 | 24.49 | 24.49 | 24.49 |
| Market Value of Quoted Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Contingent liabilities | 487.56 | 383.96 | 358.51 | 365.29 | 493.24 |
| Number of Equity shares outstanding (in Lacs) | 16.94 | 16.94 | 16.94 | 16.94 | 16.94 |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
More Information on GlaxoSmithKline Pharmaceuticals Ltd.
-
GlaxoSmithKline Pharmaceuticals Ltd. Tools
- Bulk Deals
- Block Deals
-
GlaxoSmithKline Pharmaceuticals Ltd. Company Details
- Company Profile
- Company History
- Management Team
- Capital Structure
- Product Mix
- Banker/Auditor/Registrar
-
Company History
- Bonus
- Rights
- BSE Price History
- NSE Price History
-
GlaxoSmithKline Pharmaceuticals Ltd. Key Financial Ratios
- Ratios
-
GlaxoSmithKline Pharmaceuticals Ltd. Results
- Quarterly Results
- Half Yearly Results
- Nine Months Results
- Annual Results
-
GlaxoSmithKline Pharmaceuticals Ltd. Financial Data
- Audited Results
- Cash Flow
- Balance Sheet
-
GlaxoSmithKline Pharmaceuticals Ltd. Reports
- Accounting Policies
- Auditors Report
- Directors Report
- Notes To Account
-
GlaxoSmithKline Pharmaceuticals Ltd. Corporate Announcements
- Book Closure
- Dividend
- Board Meetings
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+